Opportunities / HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Intent to Sole Source - Procurement of BD Mission™ Disposable Core Biopsy Instrument (semi-automatic, single-use)
| Notice type | Presolicitation |
|---|---|
| Solicitation # | NOI-OLAO-CC-27-000988 |
| Department | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Sub-tier / office | NATIONAL INSTITUTES OF HEALTH / NATIONAL INSTITUTES OF HEALTH - CC |
| NAICS | 339112 — Surgical and Medical Instrument Manufacturing |
| PSC | 6515 |
| Set-aside | No set-aside |
| Posted | Oct 29, 2026 |
| Response deadline | Nov 8, 2026 (2026-11-08T12:00:00-05:00) |
| Place of performance | Bethesda, MD, 20892 |
| Primary contact | Valerie Gregorio · valerie.gregorio@nih.gov |
Description (excerpt)
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Bard Peripheral Vascular Inc. Acquisition Description: Procurement of BD Mission™ Disposable Core Biopsy Instrument (semi-automatic, single-use) for use in Interventional Radiology image-guided core needle biopsy procedures. Device is compatible with the BD TruGuide™ Disposable Coaxial Biopsy Needle and is available in 14G–20G gauges and 6–25 cm lengths to accommodate a range of lesion depths and target sites. Features include Advanced Echogenic Technology for enhanced ultrasound visibility, a Fire Ready Indicator, and a penetration depth indicator (10mm/20mm presets). Core Function: Supplies required: BD Mission™ Disposable Core Biopsy Instrument(s), single-use, sterile, for IR core needle biopsy procedures. Delivery is requested on an as-needed/recurring basis via standard vendor shipment The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000988) by 12:00 PM eastern standard time on 11/08/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.